Advertisement
Screener

CAMP4 Therapeutics Corporation (CAMP) Payments of Stock Issuance Costs

2.0 / 5 stars · 6/15 Roast Me

CAMP4 Therapeutics Corporation Payments of Stock Issuance Costs

CAMP4 Therapeutics Corporation (CAMP) reported Payments of Stock Issuance Costs of $3.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-05

  • CAMP4 Therapeutics Corporation payments of stock issuance costs for the quarter ending 2024-12-31 was $4.93M.
  • CAMP4 Therapeutics Corporation payments of stock issuance costs for fiscal 2025 was $3.97M, a 30.99% decline from fiscal 2024.
  • CAMP4 Therapeutics Corporation payments of stock issuance costs for fiscal 2024 was $5.75M.
  • CAMP4 Therapeutics Corporation payments of stock issuance costs for fiscal 2023 was $0.00.
Period endPayments of Stock Issuance Costs 3 monthPayments of Stock Issuance Costs 9 monthPayments of Stock Issuance Costs 12 monthPayments of Stock Issuance Costs 12 month as first filed
2025-12-31$3.97M
10-K · filed 2026-03-05
2024-12-31$4.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$5.75M
10-K · filed 2026-03-05
$3.98M
10-K · filed 2025-03-27
2024-09-30$820.00K
10-Q · filed 2024-11-21
2023-12-31$0.00
10-K · filed 2025-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51